Shanghai Junshi Biosciences Co., Ltd. published an update regarding the shareholding increase plan of Xiong Jun, who serves as a controlling shareholder, actual controller, and chairman. According to the announcement, Xiong Jun intends to raise his holdings in both A and H shares by a total amount of not less than RMB100 million (with at least RMB50 million allocated for A shares) between April 2025 and April 2026.

As of the latest disclosure, Xiong Jun has acquired 100,000 A shares via the Shanghai Stock Exchange centralized bidding platform for RMB3,838,400, representing approximately 0.01% of the company’s current total share capital of 1,026,689,871 shares. Before the purchase, Xiong Jun directly held 87,856,618 shares (8.56%). The plan remains ongoing, and further acquisitions may occur based on market conditions.

The announcement reiterates that this shareholding increase plan could be subject to uncertainties, notably capital market fluctuations and other factors beyond the company’s control. No change in the company’s controlling shareholders or actual controllers has taken place as a result of the transaction. The board confirms that disclosures will continue in compliance with relevant listing rules throughout the shareholding increase period.